Search

everythinglearnresearchcommunity

for

Search:↓

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Hair follicles offer promising targets for delivering drugs to treat hair and skin conditions.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

Some herbs and their components might help treat hair loss by affecting various biological pathways, but more research and regulation are needed.

Panax ginseng is generally safe with mild side effects and may have health benefits, but more research is needed.

Surface-modified nanoparticles mainly use non-follicular pathways to enhance skin permeation of ibuprofen and could improve treatment for inflammatory skin diseases.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

The dietary supplement helped increase hair growth in women with hair loss.

Spironolactone plus finasteride reduces hirsutism more effectively.

High testosterone to epitestosterone ratio in hair could predict male-pattern baldness.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

Thyrotropin-Releasing Hormone helps heal wounds in frog and human skin.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

Human skin produces sex hormones like estrogen and testosterone, influenced by ARO and StAR, which may affect skin elasticity and hair growth.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

People with polycystic ovary syndrome may have a higher risk of heart problems due to abnormal nervous system control of their heart and blood pressure.

Birth control pills increase the risk of blood clots, especially within the first year and with certain types.

People with late-stage HIV-1 often experience a specific type of hair loss linked to multiple factors, including nutritional issues and immune responses.

Hair loss treatments work better with lifestyle changes.

Hormones might affect the skin condition hidradenitis suppurativa, but their exact role is unclear.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Low-level laser therapy helps male and female hair loss alone or with other treatments.

Obese women with PCOS are more likely to have fatty liver disease.

Type 3 5α-reductase is more common and finasteride and dutasteride strongly inhibit it.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.